| Literature DB >> 32711487 |
Umesh Ghimire1, Nipun Shrestha2, Bipin Adhikari3,4, Suresh Mehata5, Yashashwi Pokharel6,7, Shiva Raj Mishra8.
Abstract
BACKGROUND: The burgeoning rise of non-communicable diseases (NCDs) is posing serious challenges in resource constrained health facilities of Nepal. The main objective of this study was to assess the readiness of health facilities for cardiovascular diseases (CVDs), diabetes and chronic respiratory diseases (CRDs) services in Nepal.Entities:
Keywords: Cardiovascular diseases; Chronic respiratory disease; Diabetes; Health system; Non-communicable diseases; Service availability; Services readiness
Mesh:
Year: 2020 PMID: 32711487 PMCID: PMC7382840 DOI: 10.1186/s12889-020-09279-z
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Number of health facilities included in the current study by provinces. Geospatial map was created using GMAP procedure in SAS 9.4. The shape files were obtained from the Government of Nepal, Ministry of Federal Affairs and Local Development and were publicly available for unrestricted use (https://data.humdata.org/dataset/admin-shapefiles-of-nepal-mofald)
Fig. 2Organization of Nepal’s health system. The figure was developed by one of the authors (SRM) based on the information available from Nepal’s Ministry of Health and Population (https://mohp.gov.np/eng/)
Status of general service readiness indicators of the health facilities
| General readiness | Public facilities | Private facilities | Total |
|---|---|---|---|
| Power | 44.3 | 99.4 | 48.4 |
| Water source | 80.0 | 89.4 | 80.7 |
| Room with privacy | 76.7 | 95.7 | 78.1 |
| Adequate sanitation facilities | 80.0 | 98.4 | 81.4 |
| Communication equipment | 12.1 | 98.4 | 18.5 |
| Access to computer with internet | 4.2 | 78.7 | 9.7 |
| Emergency transportation (ambulance) | 56.4 | 94.5 | 59.2 |
| 50.5 (18.6) | 93.5 (9.6) | 53.7 (21.3) | |
| Blood pressure apparatus | 94.0 | 95.6 | 94.1 |
| Stethoscope | 97.9 | 96.7 | 97.8 |
| Adult scale | 88.2 | 94.1 | 88.6 |
| Child scale | 40.3 | 25.6 | 39.2 |
| Thermometer | 92.8 | 96.4 | 93.0 |
| Light source | 47.6 | 88.8 | 50.7 |
| 76.8 (17.5) | 82.9 (18.3) | 77.2 (17.6) | |
| Safe final disposal of sharps | 84.0 | 85.4 | 84.2 |
| Safe final disposal of infectious wastes | 81.5 | 74.6 | 81.0 |
| Appropriate storage of sharps waste | 81.1 | 34.0 | 77.6 |
| Appropriate storage of infectious waste | 4.8 | 4.7 | 4.8 |
| Disinfectant | 62.4 | 63.1 | 62.5 |
| Single-use, standard disposable or auto-disable syringes | 84.2 | 60.1 | 82.4 |
| Soap and running water or alcohol-based hand rub | 55.8 | 73.9 | 57.1 |
| Disposable latex gloves | 79.6 | 83.0 | 79.9 |
| Guidelines on standard precautions | 3.3 | 5.3 | 3.5 |
| 59.6 (18.8) | 53.8 (21.9) | 59.2 (19.1) | |
| Blood glucose test | 3.7 | 58.0 | 7.7 |
| Hemoglobin test | 9.3 | 93.3 | 15.5 |
| HIV diagnostic capacity | 8.9 | 87.1 | 14.7 |
| Malaria diagnostic capacity | 18.6 | 95.3 | 24.3 |
| Syphilis RDT | 5.6 | 78.1 | 11.0 |
| Urine test for pregnancy | 25.4 | 90.0 | 30.2 |
| Urine dipstick- protein | 9.8 | 90.5 | 15.8 |
| Urine dipstick- glucose | 7.7 | 91.8 | 14.0 |
| 11.1 (22.9) | 85.5 (21.5) | 16.6 (30.0) | |
| Amitriptyline tablet | 4.7 | 58.3 | 9.8 |
| Amlodipine tablet or alternative calcium channel blocker | 5.1 | 68.3 | 11.2 |
| Amoxicillin syrup/suspension or dispersible tablet | 21.6 | 57.4 | 24.2 |
| Amoxicillin tablet | 89.6 | 71.4 | 88.3 |
| Ampicillin powder for injection | 4.0 | 36.7 | 6.4 |
| Beclometasone inhaler | 3.2 | 33.0 | 6.0 |
| Ceftriaxone injection | 18.0 | 43.6 | 19.9 |
| Enalapril tablet or alternative ACE inhibitor e.g. lisinopril, ramipril, perindopril | 13.9 | 57.0 | 18.0 |
| Fluoxetine tablet | NA | NA | NA |
| Gentamicin injection | 63.5 | 64.4 | 63.6 |
| Glibenclamide tablet | 1.4 | 30.3 | 4.2 |
| Ibuprofen tablet | 18.0 | 74.3 | 22.2 |
| Insulin regular injection | 4.3 | 50.8 | 19.9 |
| Metformin tablet | 2.6 | 67.8 | 7.5 |
| Omeprazole tablet or alternative such as pantoprazole, rabeprazole | 46.2 | 72.8 | 48.2 |
| Oral Rehydration Solution (ORS) | 93.3 | 77.8 | 92.2 |
| Paracetamol tab/injection | 99.4 | 73.3 | 97.4 |
| Salbutamol tab or inhaler | 78.2 | 68.0 | 77.4 |
| Simvastatin tablet or other statin e.g. atorvastatin, pravastatin, fluvastatin | 0.6 | 19.5 | 2.4 |
| Zinc sulphate tab | 98.1 | 61.3 | 95.4 |
| 31.4 (10.6) | 56.0 (35.7) | 33.3 (15.5) | |
| 50.3 (42.4, 63.3) | 75.2 (65.8, 84.3) | 53.8 (43.7, 69.4) | |
Fluoxetine tablet was not available in the dataset
Ibuprofen tablet was not available in the NHFS dataset, Diclofenac was used instead
Enalapril tablet or alternative ACE inhibitor e.g. lisinopril, ramipril, perindopril was not available in the NHFS dataset, Atenolol was used instead
Readiness index scores specific to services for CVD and domain scores by facility type
| Services for CVDs | Public facilities | Private facilities | Total |
|---|---|---|---|
| Diagnosis and treatment facilities | 71.3 | 94.6 | 73.1 |
| Guidelines on diagnosis and treatmenta | 1.4 | 1.3 | 1.4 |
| 1.4 | 1.3 | 1.4 | |
| Trained staffa | 1.4 | 3.1 | 1.3 |
| 1.4 | 3.1 | 1.3 | |
| Stethoscope | 97.9 | 96.9 | 97.8 |
| Blood pressure | 93.5 | 95.7 | 93.7 |
| Adult weighing scale | 87.0 | 93.5 | 87.6 |
| Oxygen | 4.4 | 55.1 | 9.3 |
| 67.1 (20.2) | 81.2 (27.4) | 68.2 (21.1) | |
| Amlodipine/nifedipine | 5.1 | 68.3 | 11.2 |
| Beta-blockers (atenolol) | 13.9 | 57.0 | 18.0 |
| Aspirin | 4.2 | 63.5 | 9.9 |
| Thiazide | 2.1 | 26.2 | 4.4 |
| 2.6 (9.8) | 39.1 (29.0) | 5.4 (15.5) | |
| 18.8 (18.8, 18.8) | 31.3 (18.9, 37.5) | 18.8 (18.8, 25.0) | |
aThis analysis is limited to a sub-sample of Public facilities (n = 621), Private facilities (n = 66) and all combined (n = 687)
Readiness index scores specific to services for diabetes and domain scores by facility type
| Services for diabetes | Public facilities | Private facilities | Total |
|---|---|---|---|
| Diagnosis and treatment facilities | 15.1 | 95.2 | 21.1 |
| Guidelines for diagnosis and treatmenta | 4.8 | 2.5 | 4.1 |
| 4.8 | 2.5 | 4.1 | |
| Trained staffa | 1.5 | 2.5 | 1.9 |
| 1.5 | 2.5 | 1.9 | |
| Blood pressure | 93.5 | 95.7 | 94.2 |
| Adult weighing scale | 84.8 | 93.5 | 87.7 |
| Height board/stadiometer | 26.7 | 35.9 | 29.8 |
| 37.9 (22.3) | 71.4 (27.5) | 40.4 (24.4) | |
| Blood glucose | 5.5 | 24.7 | 11.9 |
| Urine protein | 39.7 | 82.2 | 53.9 |
| Urine glucose | 40.2 | 85.1 | 55.3 |
| 4.7 (17.6) | 63.1 (30.5) | 9.0 (24.3) | |
| Metformin | 16.5 | 69.5 | 34.3 |
| Glibenclamide | 6.4 | 30.1 | 14.3 |
| Injectable insulin | 4.3 | 50.8 | 19.9 |
| Injectable glucose solution | 46.7 | 69.9 | 54.5 |
| 7.7 (13.7) | 54.4 (38.0) | 11.1 (20.7) | |
| 26.4 (16.7, 30.6) | 34.7 (26.4, 40.3) | 26.4 (20.8, 33.3) | |
aThis analysis is limited to a sub-sample of Public facilities (n = 132), Private facilities (n = 66) and all combined (n = 198)
Readiness index scores specific to services for chronic respiratory diseases and domain scores by facility type
| Services for chronic respiratory diseases | Public facilities | Private facilities | Total |
|---|---|---|---|
| Both diagnosis and treatment facilities | 94.1 | 94.9 | 94.1 |
| Guidelines on the diagnosis and treatmenta | 4.9 | 0.6 | 4.6 |
| 4.9 | 0.6 | 4.6 | |
| Trained staffa | 9.4 | 3.4 | 9.0 |
| 9.4 | 3.4 | 9.0 | |
| Stethoscope | 97.8 | 96.9 | 97.7 |
| Oxygen flow meter | 2.5 | 49.3 | 6.0 |
| Spacers for inhalers | 2.1 | 25.0 | 3.8 |
| Oxygen | 3.4 | 54.9 | 7.2 |
| 25.0 (11.4) | 53.9 (33.7) | 27.2 (16.1) | |
| Salbutamol inhaler | 79.7 | 68.2 | 78.8 |
| Beclomethasone inhaler | 3.0 | 32.9 | 5.3 |
| Prednisolone cap/tabs | 3.4 | 64.9 | 8.0 |
| Hydrocortisone injection | 6.9 | 69.9 | 11.6 |
| Epinephrine injectable | 5.2 | 59.1 | 9.2 |
| 19.3 (14.3) | 57.9 (39.6) | 22.2 (20.2) | |
| 11.3 (11.3, 16.3) | 26.3 (6.5, 37.5) | 11.3 (11.3, 18.8) | |
aThis analysis is limited to a sub-sample of Public facilities (n = 819), Private facilities (n = 66) and all combined (n = 885)
Multiple regression analyses of health facility characteristics with the service readiness index
| CVDs | Diabetes | CRDs | ||||
|---|---|---|---|---|---|---|
| Adjusted β (95%CI) | Adjusted β (95%CI) | Adjusted β (95%CI) | ||||
| Province 1 | ||||||
| Province 2 | 0.83 (0.73–0.95) | 0.01 | 0.94 (0.53–1.66) | 0.89 | 1.18 (0.87–1.59) | 0.18 |
| Province 3 | 1.05 (0.92–1.19) | 0.46 | 1.38 (0.86–2.23) | 0.33 | 1.29 (0.78–2.12) | 0.28 |
| Province 4 | 1.24 (1.07–1.43) | 0.00 | 1.98 (1.08–3.61) | 0.88 | 1.36 (0.77–2.42) | 0.32 |
| Province 5 | 1.17 (1.02–1.34) | 0.02 | 1.21 (0.73–2.01) | 0.22 | 1.36 (0.77–2.42) | 0.29 |
| Province 6 | 0.01 (0.85–1.21) | 0.87 | 1.15 (0.58–2.29) | 0.83 | 0.73 (0.36–1.48) | 0.38 |
| Province 7 | 0.06 (0.91–1.24) | 0.47 | 1.34 (0.73–2.45) | 0.33 | 1.25 (0.50–3.13) | 0.63 |
| Public facilities | ||||||
| Private facilities | 2.87 (2.42–3.39) | 0.00 | 3.02 (2.03–4.49) | 0.00 | 15.95 (4.61–55.13) | 0.00 |
| Mountains | 1.88 (0.78–0.99) | 0.68 | 1.19 (−0.14–0.9) | 0.49 | 1.07 (0.89–1.30) | 0.47 |
| Hills | 1.99 (0.91–1.11) | 0.03 | 1.15 (0.78–1.707) | 0.46 | 1.13 (0.97–1.32) | 0.11 |
| Terai | ||||||
| Metropolitan | 0.99 (0.80–1.22) | 0.92 | 1.59 (0.89–2.85) | 0.12 | 0.80 (0.59–1.09) | 0.16 |
| Urban Municipality | 1.13 (1.04–1.23) | 0.01 | 1.78 (1.23–2.59) | 0.00 | 1.02 (0.90–1.16) | 0.76 |
| Rural Municipality | ||||||
adependent variable were log-transformed before analysis
βregression coefficient was calculated based on the antilog of unstandardized regression coefficient. β of ≥1 denotes favourable changes in readiness index while assessing the relationship with the predictor variable. The model is adjusted for health facility types, ecological region and urbanization
CIconfidence interval (unstandardized regression coefficient)
Fig. 3Differences between the service readiness indexes in health facilities across seven provinces (The figure shows the medians and interquartile range for cardiovascular, diabetes, and chronic respiratory disease-specific readiness index at the province level in Nepal)
Fig. 4Differences between the service readiness indexes of metropolitan, municipality, and rural health facilities